Related references
Note: Only part of the references are listed.New management algorithms in multiple sclerosis
Per Soelberg Sorensen
CURRENT OPINION IN NEUROLOGY (2014)
Relapsing and progressive forms of multiple sclerosis: insights from pathology
Ranjan Dutta et al.
CURRENT OPINION IN NEUROLOGY (2014)
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs
H. Tedeholm et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis
Afsaneh Shirani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
Douglas S. Goodin et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique
Devon S. Conway et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia
Eleonora Cocco et al.
PLOS ONE (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium
Ilya Kister et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Epidemiology of multiple sclerosis in south-western Sardinia
Eleonora Cocco et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Evidence for a two-stage disability progression in multiple sclerosis
Emmanuelle Leray et al.
BRAIN (2010)
The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
Antonio Scalfari et al.
BRAIN (2010)
New perspectives in the natural history of multiple sclerosis
Helen Tremlett et al.
NEUROLOGY (2010)
Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation
P. J. Veugelers et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Will Rogers Phenomenon in Multiple Sclerosis
Maria Pia Sormani et al.
ANNALS OF NEUROLOGY (2008)
Natural history of multiple sclerosis in a population-based cohort
M. Debouverie et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
M. G. Brown et al.
NEUROLOGY (2007)
New natural history of interferon-β treated relapsing multiple sclerosis
Maria Trojano et al.
ANNALS OF NEUROLOGY (2007)
Age at onset determines the occurrence of the progressive phase of multiple sclerosis
B. Stankoff et al.
NEUROLOGY (2007)
Immortal time bias in observational studies of drug effects
Samy Suissa
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phased of the disease (vol 129, pg 584, 2006)
M Kremenchutzky
BRAIN (2006)
Natural history of multiple sclerosis: a unifying concept
C Confavreux et al.
BRAIN (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study
JK Lunceford et al.
STATISTICS IN MEDICINE (2004)
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process
C Confavreux et al.
BRAIN (2003)
Benefit of interferon β-1a on MSFC progression in secondary progressive MS
JA Cohen et al.
NEUROLOGY (2002)
Age-related disability in multiple sclerosis
M Trojano et al.
ANNALS OF NEUROLOGY (2002)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)